–
Viking Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−55.7
FY22:
−70.4
FY23:
−101
FY24:
−151
FY25:
−393
(positive)
Change from FY21 to FY25
millions USD
FY21:
−55.4
FY22:
−70.0
FY23:
−101
FY24:
−151
FY25:
−393
(positive)
Change from FY21 to FY25
millions USD
FY21:
−55.0
FY22:
−68.9
FY23:
−85.9
FY24:
−110
FY25:
−360
(positive)
Change from FY21 to FY25
millions USD
FY21:
−55.0
FY22:
−68.9
FY23:
−85.9
FY24:
−110
FY25:
−360
All amounts in millions USD